CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,000 | +90.5% | 20,523 | +20.6% | 0.00% | – |
| Q4 2020 | $21,000 | -47.5% | 17,018 | -23.8% | 0.00% | – |
| Q3 2020 | $40,000 | -76.9% | 22,321 | +8.4% | 0.00% | -100.0% |
| Q2 2020 | $173,000 | +158.2% | 20,590 | +62.2% | 0.00% | – |
| Q1 2020 | $67,000 | -44.2% | 12,696 | -42.4% | 0.00% | -100.0% |
| Q4 2019 | $120,000 | +1.7% | 22,031 | -9.2% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -31.0% | 24,264 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $171,000 | -9.5% | 24,617 | -9.6% | 0.00% | 0.0% |
| Q1 2019 | $189,000 | +31.2% | 27,226 | +10.4% | 0.00% | 0.0% |
| Q4 2018 | $144,000 | -35.1% | 24,655 | -16.2% | 0.00% | -50.0% |
| Q3 2018 | $222,000 | +44.2% | 29,431 | -3.8% | 0.00% | +100.0% |
| Q2 2018 | $154,000 | -21.0% | 30,585 | -4.4% | 0.00% | 0.0% |
| Q1 2018 | $195,000 | -25.3% | 31,986 | -13.0% | 0.00% | -50.0% |
| Q4 2017 | $261,000 | – | 36,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |